This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffiths, P. D.
Right arrow Articles by Cheung, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffiths, P. D.
Right arrow Articles by Cheung, S.
Related Collections
Right arrow Neurology & Psychiatry

PEDIATRICS Vol. 104 No. 4 October 1999, p. e49

ELECTRONIC ARTICLE:
Neurofibromatosis Bright Objects in Children With Neurofibromatosis Type 1: A Proliferative Potential?

Received Aug 10, 1998; accepted Apr 23, 1999.

Paul D. Griffiths, FRCR, PhD*, Susan BlaserDagger , William Mukonoweshuro*, Derek ArmstrongDagger , Golda Milo-Mason§, and Sylvester CheungDagger

From the Departments of Dagger  Diagnostic Imaging and § Pediatrics, Hospital for Sick Children, Toronto, Canada; and the * Section of Academic Radiology, University of Sheffield, Sheffield, United Kingdom.

Objectives.  The purpose of this study was to investigate the natural history of the high signal intensities shown on long TR sequences---neurofibromatosis type 1 bright objects (NBO)---in children with neurofibromatosis type 1 (NF1). We have paid particular attention to the development of tumors in these areas of abnormality.

Methods.  During a 12-month period in 1992 to 1993, 46 children with clinically proven NF1 had a magnetic resonance (MR) examination at our institution. These were reviewed along with any previous or subsequent MR examinations that had been performed. We recorded the number, volume, and distribution of the abnormal high signal intensities and their change with time when serial examinations were performed.

Results.  NBO were found in 93% of 46 children with NF1 on the original cross-sectional study. The most common anatomic sites were the globus pallidus (30.4%), cerebellum (23.5%), and midbrain (16.2%). The number and volume of NBO varied significantly with age. NBO were uncommon in children younger than 4 years but were very common and extensive between 4 to 10 years. A significant reduction in the number and volume of NBO was demonstrated in children older than 10 years as shown on both the cross-sectional and longitudinal portions of the study. Eight brain tumors (nonoptic pathway) were demonstrated in the 46 children (17%) with 1 child having two tumors. Only 1 child had symptoms referable to the tumor at the time of diagnosis. Five tumors developed in NBO that were documented on serial MR examinations. All those cases developed in children aged 7 to 12 years, and all these children had higher than average numbers and volumes of NBO.

Conclusions.  NBO occur commonly in children with NF1 and are most prevalent between the ages of 4 and 10. We have shown a high frequency of brain tumors in our children with NF1, but the majority of these were asymptomatic. We have demonstrated proliferative change NBO in 11% of 46 children. Most NBO regress with age and seem to be benign, however, young children with a large number and volume of NBO should be followed closely with regular MR examinations because of an increased risk of proliferative change. neurofibromatosis type 1, magnetic resonance, tumor, astrocytoma, childhood. .




This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
S.L. Zamboni, T. Loenneker, E. Boltshauser, E. Martin, and K.A. Il'yasov
Contribution of Diffusion Tensor MR Imaging in Detecting Cerebral Microstructural Changes in Adults with Neurofibromatosis Type 1
AJNR Am. J. Neuroradiol., April 1, 2007; 28(4): 773 - 776.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
L. Margari, A. Presicci, P. Ventura, S. M. Bacca, G. Iliceto, N. Medicamento, M. Buttiglione, and T. Perniola
Clinical and Instrumental (Magnetic Resonance Imaging [MRI] and Multimodal Evoked Potentials) Follow-Up of Brain Lesions in Three Young Patients With Neurofibromatosis 1
J Child Neurol, December 1, 2006; 21(12): 1085 - 1090.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
W. H. S. Goh, P.-L. Khong, C. S. Y. Leung, and V. C. N. Wong
T 2-Weighted Hyperintensities (Unidentified Bright Objects) in Children With Neurofibromatosis 1: Their Impact on Cognitive Function
J Child Neurol, November 1, 2004; 19(11): 853 - 858.
[Abstract] [PDF]

Home page
 Am. J. Neuroradiol.Home page
R. G. Steen, J. S. Taylor, J. W. Langston, J. O. Glass, V. R. Brewer, W. E. Reddick, R. Mages, and E. K. Pivnick
Prospective Evaluation of the Brain in Asymptomatic Children with Neurofibromatosis Type 1: Relationship of Macrocephaly to T1 Relaxation Changes and Structural Brain Abnormalities
AJNR Am. J. Neuroradiol., May 1, 2001; 22(5): 810 - 817.
[Abstract] [Full Text]

Home page
 NeurologyHome page
K. DeBella, K. Poskitt, J. Szudek, and J. M. Friedman
Use of ""unidentified bright objects"" on MRI for diagnosis of neurofibromatosis 1 in children
Neurology, April 25, 2000; 54(8): 1646 - 1651.
[Abstract] [Full Text] [PDF]